标题
Targeting Head and Neck Cancer by Vaccination
作者
关键词
-
出版物
Frontiers in Immunology
Volume 9, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2018-04-23
DOI
10.3389/fimmu.2018.00830
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Linear doggybone DNA vaccine induces similar immunological responses to conventional plasmid DNA independently of immune recognition by TLR9 in a pre-clinical model
- (2018) Alex Allen et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Signaling by the Epstein–Barr virus LMP1 protein induces potent cytotoxic CD4+and CD8+T cell responses
- (2018) Il-Kyu Choi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Monitoring T cell–dendritic cell interactions in vivo by intercellular enzymatic labelling
- (2018) Giulia Pasqual et al. NATURE
- Targeting the Myofibroblastic Cancer-Associated Fibroblast Phenotype Through Inhibition of NOX4
- (2017) Christopher J Hanley et al. JNCI-Journal of the National Cancer Institute
- Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
- (2017) Ugur Sahin et al. NATURE
- An immunogenic personal neoantigen vaccine for patients with melanoma
- (2017) Patrick A. Ott et al. NATURE
- Neoantigens in immunotherapy and personalized vaccines: Implications for head and neck squamous cell carcinoma
- (2017) Paul Zolkind et al. ORAL ONCOLOGY
- Epstein-Barr virus (EBV)-encoded small RNAs (EBERs) associated with poor prognosis of head and neck carcinomas
- (2017) Turunen Aaro et al. Oncotarget
- Phase I clinical trial of idiotypic DNA vaccine administered as a complex with polyethylenimine to patients with B-cell lymphoma
- (2017) A. N. Meleshko et al. Human Vaccines & Immunotherapeutics
- Targeting the Myofibroblastic Cancer-Associated Fibroblast Phenotype Through Inhibition of NOX4
- (2017) Christopher J Hanley et al. JNCI-Journal of the National Cancer Institute
- MVX-ONCO-1 phase 1 final results of the first personalized cell-based immunotherapy using cell encapsulation technology
- (2016) N. Mach et al. ANNALS OF ONCOLOGY
- Abstract LB-095: HPV E7 antigen-expressing Listeria-based immunotherapy (ADXS11-001) prior to robotic surgery for HPV-positive oropharyngeal cancer enhances HPV-specific T cell immunity
- (2016) Rosemarie Krupar et al. CANCER RESEARCH
- Upregulated Glucose Metabolism Correlates Inversely with CD8 + T-cell Infiltration and Survival in Squamous Cell Carcinoma
- (2016) Christian H. Ottensmeier et al. CANCER RESEARCH
- HPV-Related Oropharynx Cancer in the United Kingdom: An Evolution in the Understanding of Disease Etiology
- (2016) Andrew G. Schache et al. CANCER RESEARCH
- The Safety and Immunological Effects of rAd5-EBV-LMP2 Vaccine in Nasopharyngeal Carcinoma Patients: A Phase I Clinical Trial and Two-Year Follow-Up
- (2016) Yongfeng Si et al. CHEMICAL & PHARMACEUTICAL BULLETIN
- Targeting Carcinoembryonic Antigen with DNA Vaccination: On-Target Adverse Events Link with Immunologic and Clinical Outcomes
- (2016) K. J. McCann et al. CLINICAL CANCER RESEARCH
- Vaccination against Oncoproteins of HPV16 for Noninvasive Vulvar/Vaginal Lesions: Lesion Clearance Is Related to the Strength of the T-Cell Response
- (2016) M. I. E. van Poelgeest et al. CLINICAL CANCER RESEARCH
- A pilot study of pNGVL4a-CRT/E7(detox) for the treatment of patients with HPV16 + cervical intraepithelial neoplasia 2/3 (CIN2/3)
- (2016) Ronald D. Alvarez et al. GYNECOLOGIC ONCOLOGY
- The present status and future prospects of peptide-based cancer vaccines
- (2016) Masatoshi Hirayama et al. INTERNATIONAL IMMUNOLOGY
- Antitumor Activity of Pembrolizumab in Biomarker-Unselected Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results From the Phase Ib KEYNOTE-012 Expansion Cohort
- (2016) Laura Q.M. Chow et al. JOURNAL OF CLINICAL ONCOLOGY
- TG4010 immunotherapy and first-line chemotherapy for advanced non-small-cell lung cancer (TIME): results from the phase 2b part of a randomised, double-blind, placebo-controlled, phase 2b/3 trial
- (2016) Elisabeth Quoix et al. LANCET ONCOLOGY
- Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy
- (2016) Lena M. Kranz et al. NATURE
- Vaccination during myeloid cell depletion by cancer chemotherapy fosters robust T cell responses
- (2016) Marij J. Welters et al. Science Translational Medicine
- HPV 16 E5 oncoprotein is expressed in early stage carcinogenesis and can be a target of immunotherapy
- (2016) Francesca Paolini et al. Human Vaccines & Immunotherapeutics
- Carcinogenic human papillomavirus infection
- (2016) Mark Schiffman et al. Nature Reviews Disease Primers
- Immunotherapy of HPV-associated cancer: DNA/plant-derived vaccines and new orthotopic mouse models
- (2015) Aldo Venuti et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Encapsulated Cellular Implants for Recombinant Protein Delivery and Therapeutic Modulation of the Immune System
- (2015) Aurélien Lathuilière et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Therapeutic cancer vaccines
- (2015) Cornelis J.M. Melief et al. JOURNAL OF CLINICAL INVESTIGATION
- Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trial
- (2015) Cornelia L Trimble et al. LANCET
- A Comprehensive Expression Analysis of Cancer Testis Antigens in Head and Neck Squamous Cell Carcinoma Revels MAGEA3/6 as a Marker for Recurrence
- (2015) F. T. Zamuner et al. MOLECULAR CANCER THERAPEUTICS
- A novel “priming-boosting” strategy for immune interventions in cervical cancer
- (2015) Shujie Liao et al. MOLECULAR IMMUNOLOGY
- Mutant MHC class II epitopes drive therapeutic immune responses to cancer
- (2015) Sebastian Kreiter et al. NATURE
- Neoantigens in cancer immunotherapy
- (2015) T. N. Schumacher et al. SCIENCE
- Innate immune recognition of DNA: A recent history
- (2015) Alan Dempsey et al. VIROLOGY
- Recent Progress in Therapeutic Treatments and Screening Strategies for the Prevention and Treatment of HPV-Associated Head and Neck Cancer
- (2015) Sonia Whang et al. Viruses-Basel
- Immunotherapy with VGX-3100 (HPV16 and HPV18 plasmids) + INO-9012 (DNA encoding IL-12) in human papillomavirus (HPV) associated head and neck squamous cell carcinoma (HNSCCa): interim safety and immunogenicity results
- (2015) Charu Aggarwal et al. Journal for ImmunoTherapy of Cancer
- Head and Neck Cancer: Global Burden and Regional Trends in India
- (2014) Anupam Mishra et al. Asian Pacific Journal of Cancer Prevention
- Phase I Dendritic Cell p53 Peptide Vaccine for Head and Neck Cancer
- (2014) P. J. Schuler et al. CLINICAL CANCER RESEARCH
- A Recombinant Modified Vaccinia Ankara Vaccine Encoding Epstein-Barr Virus (EBV) Target Antigens: A Phase I Trial in UK Patients with EBV-Positive Cancer
- (2014) G. S. Taylor et al. CLINICAL CANCER RESEARCH
- Phase II Clinical Trial of Multiple Peptide Vaccination for Advanced Head and Neck Cancer Patients Revealed Induction of Immune Responses and Improved OS
- (2014) Y. Yoshitake et al. CLINICAL CANCER RESEARCH
- Integrative and Comparative Genomic Analysis of HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinomas
- (2014) Tanguy Y. Seiwert et al. CLINICAL CANCER RESEARCH
- The role of sexual behavior in head and neck cancer: implications for prevention and therapy
- (2014) Eleni Rettig et al. Expert Review of Anticancer Therapy
- Regression of Human Papillomavirus Intraepithelial Lesions Is Induced by MVA E2 Therapeutic Vaccine
- (2014) Ricardo Rosales et al. HUMAN GENE THERAPY
- Epstein-Barr Virus and Human Papillomavirus Infections and Genotype Distribution in Head and Neck Cancers
- (2014) Zeyi Deng et al. PLoS One
- Alphavirus-Based Vaccines
- (2014) Kenneth Lundstrom Viruses-Basel
- Overexpressed oncogenic tumor-self antigens
- (2014) Robert K Bright et al. Human Vaccines & Immunotherapeutics
- How Do CD4+ T Cells Detect and Eliminate Tumor Cells That Either Lack or Express MHC Class II Molecules?
- (2014) Ole Audun Werner Haabeth et al. Frontiers in Immunology
- The long-term immune response after HPV16 peptide vaccination in women with low-grade pre-malignant disorders of the uterine cervix: a placebo-controlled phase II study
- (2013) Peggy J. de Vos van Steenwijk et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Worldwide Trends in Incidence Rates for Oral Cavity and Oropharyngeal Cancers
- (2013) Anil K. Chaturvedi et al. JOURNAL OF CLINICAL ONCOLOGY
- HPV16 E5 peptide vaccine in treatment of cervical cancer in vitro and in vivo
- (2013) Shu-jie Liao et al. Journal of Huazhong University of Science and Technology-Medical Sciences
- HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trial
- (2013) Mariette I E van Poelgeest et al. Journal of Translational Medicine
- Innate and adaptive immune cells in the tumor microenvironment
- (2013) Thomas F Gajewski et al. NATURE IMMUNOLOGY
- Promising systemic immunotherapies in head and neck squamous cell carcinoma
- (2013) Neil Gildener-Leapman et al. ORAL ONCOLOGY
- The Papillomavirus E2 proteins
- (2013) Alison A. McBride VIROLOGY
- Human papillomavirus oncoproteins and apoptosis (Review)
- (2013) PEIYUE JIANG et al. Experimental and Therapeutic Medicine
- Mining the mutanome: developing highly personalized Immunotherapies based on mutational analysis of tumors
- (2013) Willem W Overwijk et al. Journal for ImmunoTherapy of Cancer
- DNA fusion-gene vaccination in patients with prostate cancer induces high-frequency CD8+ T-cell responses and increases PSA doubling time
- (2012) Lindsey Chudley et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Dissection of T-cell Antigen Specificity in Human Melanoma
- (2012) R. S. Andersen et al. CANCER RESEARCH
- inducTION of mage-A3 and HPV-16 immunity by Trojan vaccines in patients with head and neck carcinoma
- (2012) Caroline J. Voskens et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Multicenter, phase II clinical trial of cancer vaccination for advanced esophageal cancer with three peptides derived from novel cancer-testis antigens
- (2012) Koji Kono et al. Journal of Translational Medicine
- PRAME expression in head and neck cancer correlates with markers of poor prognosis and might help in selecting candidates for retinoid chemoprevention in pre-malignant lesions
- (2012) Miroslaw J. Szczepanski et al. ORAL ONCOLOGY
- Whole Cell Vaccines—Past Progress and Future Strategies
- (2012) Bridget P. Keenan et al. SEMINARS IN ONCOLOGY
- A Review of Clinical Trials of Human Papillomavirus Prophylactic Vaccines
- (2012) John T. Schiller et al. VACCINE
- Widespread CD4+ T-cell reactivity to novel hTERT epitopes following vaccination of cancer patients with a single hTERT peptide GV1001
- (2012) Else-Marit Inderberg-Suso et al. OncoImmunology
- Regression of high-grade cervical intraepithelial neoplasia with TG4001 targeted immunotherapy
- (2011) Jean-Luc Brun et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Immune Suppression in Head and Neck Cancers: A Review
- (2011) Anaëlle Duray et al. Clinical & Developmental Immunology
- Improvement of different vaccine delivery systems for cancer therapy
- (2011) Azam Bolhassani et al. Molecular Cancer
- The Mutational Landscape of Head and Neck Squamous Cell Carcinoma
- (2011) N. Stransky et al. SCIENCE
- Phase I clinical trial of survivin-derived peptide vaccine therapy for patients with advanced or recurrent oral cancer
- (2010) Akihiro Miyazaki et al. CANCER SCIENCE
- Living with oral cancer: Epidemiology with particular reference to prevalence and life-style changes that influence survival
- (2010) Saman Warnakulasuriya ORAL ONCOLOGY
- Success or failure of vaccination for HPV16-positive vulvar lesions correlates with kinetics and phenotype of induced T-cell responses
- (2010) M. J. P. Welters et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- 1st International Workshop on Papillomavirus E5 Oncogene—A report
- (2010) Giuseppe Borzacchiello et al. VIROLOGY
- Interaction between Tobacco and Alcohol Use and the Risk of Head and Neck Cancer: Pooled Analysis in the International Head and Neck Cancer Epidemiology Consortium
- (2009) M. Hashibe et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Vaccination with multiple peptides derived from novel cancer-testis antigens can induce specific T-cell responses and clinical responses in advanced esophageal cancer
- (2009) Koji Kono et al. CANCER SCIENCE
- DNA Vaccination with Electroporation Induces Increased Antibody Responses in Patients with Prostate Cancer
- (2009) Lindsey Low et al. HUMAN GENE THERAPY
- The role of human papillomavirus in the increased incidence of base of tongue cancer
- (2009) Per Attner et al. INTERNATIONAL JOURNAL OF CANCER
- Characterization of Preexisting MAGE-A3-Specific CD4+ T Cells in Cancer Patients and Healthy Individuals and Their Activation by Protein Vaccination
- (2009) T. Tsuji et al. JOURNAL OF IMMUNOLOGY
- Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia
- (2009) Gemma G. Kenter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Administration of HPV DNA vaccine via electroporation elicits the strongest CD8+ T cell immune responses compared to intramuscular injection and intradermal gene gun delivery
- (2009) Simon R. Best et al. VACCINE
- HPV & head and neck cancer: a descriptive update
- (2009) Peter KC Goon et al. Head and Neck Optical Diagnostics Society
- Epitope Landscape in Breast and Colorectal Cancer
- (2008) N. H. Segal et al. CANCER RESEARCH
- Host responses to alphavirus infection
- (2008) Kate D. Ryman et al. IMMUNOLOGICAL REVIEWS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now